Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Interactions of HIV and Drugs of Abuse
Kurt F. Hauser, Pamela E. Knapp
International review of neurobiology (2014), pp. 231-313
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Alcohol Use and Human Immunodeficiency Virus (HIV) Infection: Current Knowledge, Implications, and Future Directions
Emily C. Williams, Judith A. Hahn, Richard Saitz, et al.
Alcoholism Clinical and Experimental Research (2016) Vol. 40, Iss. 10, pp. 2056-2072
Open Access | Times Cited: 249
HIV, Tat and dopamine transmission
Peter J. Gaskill, Douglas R. Miller, Joyonna Gamble‐George, et al.
Neurobiology of Disease (2017) Vol. 105, pp. 51-73
Open Access | Times Cited: 69
The neurobiology of HIV and its impact on cognitive reserve: A review of cognitive interventions for an aging population
Shameka L. Cody, David E. Vance
Neurobiology of Disease (2016) Vol. 92, pp. 144-156
Closed Access | Times Cited: 68
Risk Factors and Pathogenesis of HIV-Associated Neurocognitive Disorder: The Role of Host Genetics
Ian Simon Olivier, Ramón Cacabelos, Vinogran Naidoo
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 11, pp. 3594-3594
Open Access | Times Cited: 62
The cross-talk of HIV-1 Tat and methamphetamine in HIV-associated neurocognitive disorders
Sonia Mediouni, Maria Cecília Garibaldi Marcondes, Courtney A. Miller, et al.
Frontiers in Microbiology (2015) Vol. 6
Open Access | Times Cited: 56
The Effects of Opioids on HIV Neuropathogenesis
Aniella Murphy, John M. Barbaro, Pablo Martínez-Aguado, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 54
The Ever-Changing Morphology of Hippocampal Granule Neurons in Physiology and Pathology
María Llorens‐Martin, Alberto Rábano, Jesús Ávila
Frontiers in Neuroscience (2016) Vol. 9
Open Access | Times Cited: 51
The single-cell opioid responses in the context of HIV (SCORCH) consortium
Seth A. Ament, Rianne R. Campbell, Mary Kay Lobo, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 12, pp. 3950-3961
Open Access | Times Cited: 6
Effects of Antiretroviral Treatment on Central and Peripheral Immune Response in Mice with EcoHIV Infection
Qiaowei Xie, Mark D. Namba, Lauren A. Buck, et al.
Cells (2024) Vol. 13, Iss. 10, pp. 882-882
Open Access | Times Cited: 5
Methamphetamine increases HIV infectivity in neural progenitor cells
Marta Skowrońska, Marisa McDonald, Martina Velichkovska, et al.
Journal of Biological Chemistry (2017) Vol. 293, Iss. 1, pp. 296-311
Open Access | Times Cited: 44
New Insights into the Potential Roles of 3-Iodothyronamine (T1AM) and Newly Developed Thyronamine-Like TAAR1 Agonists in Neuroprotection
Lorenza Bellusci, Annunziatina Laurino, Martina Sabatini, et al.
Frontiers in Pharmacology (2017) Vol. 8
Open Access | Times Cited: 41
Methamphetamine and Cannabis: A Tale of Two Drugs and their Effects on HIV, Brain, and Behavior
Rowan Saloner, Jerel Adam Fields, Maria Cecília Garibaldi Marcondes, et al.
Journal of Neuroimmune Pharmacology (2020) Vol. 15, Iss. 4, pp. 743-764
Open Access | Times Cited: 33
Advancing the preclinical study of comorbid neuroHIV and substance use disorders: Current perspectives and future directions
Mark D. Namba, Qiaowei Xie, Jacqueline M. Barker
Brain Behavior and Immunity (2023) Vol. 113, pp. 453-475
Open Access | Times Cited: 13
Central HIV-1 Tat exposure elevates anxiety and fear conditioned responses of male mice concurrent with altered mu-opioid receptor-mediated G-protein activation and β-arrestin 2 activity in the forebrain
Yun K. Hahn, Jason J. Paris, Aron H. Lichtman, et al.
Neurobiology of Disease (2016) Vol. 92, pp. 124-136
Open Access | Times Cited: 35
Opioid and neuroHIV Comorbidity – Current and Future Perspectives
Sylvia Fitting, MaryPeace McRae, Kurt F. Hauser
Journal of Neuroimmune Pharmacology (2020) Vol. 15, Iss. 4, pp. 584-627
Open Access | Times Cited: 31
Cocaine and HIV‐1 Tat disrupt cholesterol homeostasis in astrocytes: Implications for HIV‐associated neurocognitive disorders in cocaine user patients
Bianca Cotto, Kalimuthusamy Natarajaseenivasan, Kimberly Ferrero, et al.
Glia (2018) Vol. 66, Iss. 4, pp. 889-902
Open Access | Times Cited: 28
Opiate Addiction Therapies and HIV-1 Tat: Interactive Effects on Glial [Ca<sup>2+</sup>]<sub>i</sub>, Oxyradical and Neuroinflammatory Chemokine Production and Correlative Neurotoxicity
Sylvia Fitting, Shiping Zou, Nazira El‐Hage, et al.
Current HIV Research (2015) Vol. 12, Iss. 6, pp. 424-434
Open Access | Times Cited: 25
Review and Meta-Analyses of TAAR1 Expression in the Immune System and Cancers
Lisa M. Fleischer, Rachana Deven Somaiya, Gregory M. Miller
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 24
Morphine counteracts the antiviral effect of antiretroviral drugs and causes upregulation of p62/SQSTM1 and histone-modifying enzymes in HIV-infected astrocytes
Myosotys Rodriguez, Jessica Lapierre, Chet Raj Ojha, et al.
Journal of NeuroVirology (2019) Vol. 25, Iss. 2, pp. 263-274
Open Access | Times Cited: 24
Cell-type specific differences in antiretroviral penetration and the effects of HIV-1 Tat and morphine among primary human brain endothelial cells, astrocytes, pericytes, and microglia
Sulay Patel, Omnia A. Ismaiel, William Mylott, et al.
Neuroscience Letters (2019) Vol. 712, pp. 134475-134475
Open Access | Times Cited: 23
Role of macrophages in HIV pathogenesis and cure: NIH perspectives
Jeymohan Joseph, William Daley, Diane M. Lawrence, et al.
Journal of Leukocyte Biology (2022) Vol. 112, Iss. 5, pp. 1233-1243
Closed Access | Times Cited: 13
A client-centered relational framework on barriers to the integration of HIV and substance use services: a systematic review
Rogério M. Pinto, Yun Chen, Sunggeun Park
Harm Reduction Journal (2019) Vol. 16, Iss. 1
Open Access | Times Cited: 22
Monoacylglycerol Lipase Inhibitor MJN110 Reduces Neuronal Hyperexcitability, Restores Dendritic Arborization Complexity, and Regulates Reward-Related Behavior in Presence of HIV-1 Tat
Alexis F. League, Benjamin L. Gorman, Douglas J. Hermes, et al.
Frontiers in Neurology (2021) Vol. 12
Open Access | Times Cited: 16
Interaction of drugs of abuse and microRNA with HIV: a brief review
Sudheesh Pilakka‐Kanthikeel, Madhavan Nair
Frontiers in Microbiology (2015) Vol. 6
Open Access | Times Cited: 19
Escalating morphine dosing in HIV-1 Tat transgenic mice with sustained Tat exposure reveals an allostatic shift in neuroinflammatory regulation accompanied by increased neuroprotective non-endocannabinoid lipid signaling molecules and amino acids
Douglas J. Hermes, Ian R. Jacobs, Megan C. Key, et al.
Journal of Neuroinflammation (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top